Search results
Results from the WOW.Com Content Network
Advanced Accelerator Applications (AAA or Adacap) is a France-based pharmaceutical group, specialized in the field of nuclear medicine. [1] The group operates in all three segments of nuclear medicine (PET, SPECT and therapy) to diagnose and treat serious conditions in the fields of oncology, neurology, cardiology, infectious and inflammatory diseases.
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland.Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022.
In 2014, Novartis acquired a number of GSK's oncology products, including the collaboration with Genmab and ofatumumab. [15] [32] For commercial reasons ofatumumab (Arzerra) was withdrawn from the Canadian market in 2017. [30] [31] It was withdrawn from the European Union in February 2019.
Novartis agreed to acquire U.S. radiopharmaceutical company Mariana Oncology for $1 billion upfront, boosting its portfolio of precision cancer treatments in development, the Swiss drug ...
Reuters first reported on Monday that Switzerland-based Novartis was in advanced talks to acquire MorphoSys, leading to the German biotech firm's shares surging more than 40%. The Swiss group will ...
Novartis made use of the EMR to obtain orders against some generic manufacturers who had already launched Gleevec in India. [ 83 ] [ 84 ] When examination of Novartis' patent application began in 2005, it came under immediate attack from oppositions initiated by generic companies that were already selling Gleevec in India and by advocacy groups.
Pages in category "Drugs developed by Novartis" The following 135 pages are in this category, out of 135 total. This list may not reflect recent changes. A.
Pazopanib, sold under the brand name Votrient, is an anti-cancer medication marketed worldwide by Novartis.It is a potent and selective multi-targeted receptor tyrosine kinase inhibitor that blocks tumour growth and inhibits angiogenesis.